- Home
- GETY vs IMNM Comparison
GETY vs IMNM Comparison
Compare GETY & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GETY
- IMNM
- Stock Information
- Founded
- GETY 1995
- IMNM 2006
- Country
- GETY United States
- IMNM United States
- Employees
- GETY N/A
- IMNM N/A
- Industry
- GETY Industrial Machinery/Components
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- GETY Industrials
- IMNM Health Care
- Exchange
- GETY Nasdaq
- IMNM Nasdaq
- Market Cap
- GETY 644.9M
- IMNM 542.6M
- IPO Year
- GETY N/A
- IMNM 2020
- Fundamental
- Price
- GETY $1.73
- IMNM $7.91
- Analyst Decision
- GETY Hold
- IMNM Strong Buy
- Analyst Count
- GETY 5
- IMNM 6
- Target Price
- GETY $4.60
- IMNM $26.00
- AVG Volume (30 Days)
- GETY 1.2M
- IMNM 1.7M
- Earning Date
- GETY 05-08-2025
- IMNM 05-13-2025
- Dividend Yield
- GETY N/A
- IMNM N/A
- EPS Growth
- GETY 99.37
- IMNM N/A
- EPS
- GETY 0.10
- IMNM N/A
- Revenue
- GETY $939,287,000.00
- IMNM $9,041,000.00
- Revenue This Year
- GETY $2.37
- IMNM N/A
- Revenue Next Year
- GETY $2.59
- IMNM $1,259.12
- P/E Ratio
- GETY $17.90
- IMNM N/A
- Revenue Growth
- GETY 2.48
- IMNM N/A
- 52 Week Low
- GETY $1.25
- IMNM $5.15
- 52 Week High
- GETY $4.49
- IMNM $19.07
- Technical
- Relative Strength Index (RSI)
- GETY 46.75
- IMNM 55.28
- Support Level
- GETY $1.25
- IMNM $6.96
- Resistance Level
- GETY $1.62
- IMNM $7.56
- Average True Range (ATR)
- GETY 0.13
- IMNM 0.69
- MACD
- GETY 0.03
- IMNM 0.26
- Stochastic Oscillator
- GETY 90.57
- IMNM 98.22
About GETY Getty Images Holdings Inc.
Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.